Update Venetoclax in CLL
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
Obinutuzumab
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN Guidelines for Patients for CLL
CLL Society
UpToDate